---
title: Newsroom | Clinical Diagnostics
description: Clinical Diagnostics |
---

[![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/)

- [Newsroom](https://news.lifesciencenewswire.com/newsroom)
- [Back to the main site](https://lifesciencenewswire.com/)

![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1")

# Newsroom

#### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow")

#### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg)

![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg)

### Choose a Category

- [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture)
- [AI (2)](https://news.lifesciencenewswire.com/newsroom/tag/ai)
- [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry)
- [Biomanufacturing (35)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing)
- [biopharma (23)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)
- [Bioprocessing (16)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing)
- [Biotechnology (252)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology)
- [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture)
- [Clinical Diagnostics (38)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)
- [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research)
- [Clinical Research & Trials (117)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials)
- [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it)
- [Corporate, Finance & Investor (288)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)
- [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19)
- [Diagnostics & Hospital Laboratory (38)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory)
- [Digital Pathology (2)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology)
- [Drug Discovery & Development (153)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development)
- [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment)
- [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients)
- [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage)
- [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry)
- [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory)
- [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science)
- [Healthcare (136)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare)
- [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management)
- [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science)
- [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing)
- [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science)
- [Medical Devices & Technology (26)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology)
- [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control)
- [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging)
- [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech)
- [Omics & Genetics (87)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics)
- [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology)
- [Pharma (118)](https://news.lifesciencenewswire.com/newsroom/tag/pharma)
- [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy)
- [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research)
- [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary)
- [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water)

See all

### Subscribe to Email Updates

<https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance>

 Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Diagnostics & Hospital Laboratory](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)

#### [Scope’s CRISPR Molecular Diagnostics CE Marked for Antifungal Resistance](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance)

 October 6, 2026

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Oct 6, 2026, 1:30:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development>

 Categories: [Diagnostics & Hospital Laboratory](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics), [biopharma](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)

#### [CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development)

 October 5, 2026

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Oct 5, 2026, 2:15:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/leica-biosystems-and-cellcarta-expand-collaborative-companion-diagnostic-development-model-to-accelerate-commercialization-globally>

 Categories: [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics), [biopharma](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)

#### [Leica Biosystems and CellCarta expand collaborative companion diagnostic development model to accelerate commercialization globally](https://news.lifesciencenewswire.com/newsroom/leica-biosystems-and-cellcarta-expand-collaborative-companion-diagnostic-development-model-to-accelerate-commercialization-globally)

 June 1, 2026

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/leica-biosystems-and-cellcarta-expand-collaborative-companion-diagnostic-development-model-to-accelerate-commercialization-globally)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/leica-biosystems-and-cellcarta-expand-collaborative-companion-diagnostic-development-model-to-accelerate-commercialization-globally#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 1, 2026, 2:18:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/cellcarta-and-sonic-healthcare-establish-strategic-partnership-to-commercialize-companion-diagnostics-through-lab-network>

 Categories: [Diagnostics & Hospital Laboratory](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)

#### [CellCarta and Sonic Healthcare Establish Strategic Partnership to Commercialize Companion Diagnostics Through Lab Network](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-sonic-healthcare-establish-strategic-partnership-to-commercialize-companion-diagnostics-through-lab-network)

 May 27, 2026

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-sonic-healthcare-establish-strategic-partnership-to-commercialize-companion-diagnostics-through-lab-network)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-sonic-healthcare-establish-strategic-partnership-to-commercialize-companion-diagnostics-through-lab-network#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on May 27, 2026, 4:14:48 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/medix-biochemica-announces-5-million-investment-to-expand-recombinant-antigen-capabilities>

 Categories: [Biomanufacturing](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)

#### [Medix Biochemica announces $5 million investment to expand recombinant antigen capabilities](https://news.lifesciencenewswire.com/newsroom/medix-biochemica-announces-5-million-investment-to-expand-recombinant-antigen-capabilities)

 May 18, 2026

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/medix-biochemica-announces-5-million-investment-to-expand-recombinant-antigen-capabilities)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/medix-biochemica-announces-5-million-investment-to-expand-recombinant-antigen-capabilities#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on May 18, 2026, 1:30:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/medix-biochemica-appoints-petra-furu-as-chief-executive-officer>

 Categories: [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)

#### [Medix Biochemica appoints Petra Furu as Chief Executive Officer](https://news.lifesciencenewswire.com/newsroom/medix-biochemica-appoints-petra-furu-as-chief-executive-officer)

 April 15, 2026

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/medix-biochemica-appoints-petra-furu-as-chief-executive-officer)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/medix-biochemica-appoints-petra-furu-as-chief-executive-officer#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Apr 15, 2026, 8:00:00 AM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/cellcarta-and-pillar-biosciences-announce-multi-year-global-strategic-partnership-to-expand-rapid-decentralized-tumor-profiling-for-oncology-clinical-trials>

 Categories: [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)

#### [CellCarta and Pillar Biosciences announce multi-year global strategic partnership to expand rapid, decentralized tumor profiling for oncology clinical trials](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-pillar-biosciences-announce-multi-year-global-strategic-partnership-to-expand-rapid-decentralized-tumor-profiling-for-oncology-clinical-trials)

 April 2, 2026

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-pillar-biosciences-announce-multi-year-global-strategic-partnership-to-expand-rapid-decentralized-tumor-profiling-for-oncology-clinical-trials)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-pillar-biosciences-announce-multi-year-global-strategic-partnership-to-expand-rapid-decentralized-tumor-profiling-for-oncology-clinical-trials#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Apr 2, 2026, 1:15:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/eazebio-and-uc-santa-cruz-announce-strategic-partnership-to-advance-instrument-free-diagnostic-platform>

 Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)

#### [EazeBio and UC Santa Cruz announce strategic partnership to advance instrument-free diagnostic platform](https://news.lifesciencenewswire.com/newsroom/eazebio-and-uc-santa-cruz-announce-strategic-partnership-to-advance-instrument-free-diagnostic-platform)

 October 29, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/eazebio-and-uc-santa-cruz-announce-strategic-partnership-to-advance-instrument-free-diagnostic-platform)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/eazebio-and-uc-santa-cruz-announce-strategic-partnership-to-advance-instrument-free-diagnostic-platform#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Oct 29, 2025, 12:00:01 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/aptamer-group-introduces-novel-biomarker-discovery-service>

 Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)

#### [Aptamer Group introduces novel biomarker discovery service](https://news.lifesciencenewswire.com/newsroom/aptamer-group-introduces-novel-biomarker-discovery-service)

 August 28, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/aptamer-group-introduces-novel-biomarker-discovery-service)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/aptamer-group-introduces-novel-biomarker-discovery-service#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Aug 28, 2025, 12:15:00 PM

- [Tweet](https://twitter.com/share)

[All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics/page/2)

##### Browse more news

## Recent releases

<https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance>

#### [Scope’s CRISPR Molecular Diagnostics CE Marked for Antifungal Resistance](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance)

 October 6, 2026

Developed with AmplexDiagnostics, eazySNP brings scopeDx® into human diagnostics Scope Biosciences B.V., a Wageningen University spinoff life sciences...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance)

<https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development>

#### [CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development)

 October 5, 2026

Collaboration combines CellCarta’s global clinical trial testing capabilities with Waters’ standardized flow cytometry platforms and expertise CellCar...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development)

<https://news.lifesciencenewswire.com/newsroom/cellcarta-and-imagene-ai-expand-collaboration-to-validate-deploy-and-scale-ai-powered-biomarker-and-companion-diagnostic-programs-across-drug-development>

#### [CellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and...](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-imagene-ai-expand-collaboration-to-validate-deploy-and-scale-ai-powered-biomarker-and-companion-diagnostic-programs-across-drug-development)

 October 1, 2026

The collaboration combines Imagene’s AI-powered assay development and biomarker prediction capabilities with CellCarta’s global companion diagnostics ...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-imagene-ai-expand-collaboration-to-validate-deploy-and-scale-ai-powered-biomarker-and-companion-diagnostic-programs-across-drug-development)

![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse")

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225 

#### Useful information

- [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/)
- [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions)
- [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)